[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100570771":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":17,"locations":22,"responsibleParty":38,"collaborators":41,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":7,"eligibilityCriteria":49,"healthyVolunteers":46,"sex":50,"minAge":7,"maxAge":7,"enrollmentInfo":51,"targetDuration":7,"studyType":54,"phases":7,"briefSummary":55,"conditions":56,"keywords":7,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"Shandong University","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DRUG","Anti-Infective Drugs","Anti-infective drugs are administered using the traditional clinical dosing regimen, with no interventions.",[14],{"name":15,"affiliation":5,"role":16},"Wei Zhao, Ph.D","PRINCIPAL_INVESTIGATOR",[18],{"name":15,"role":19,"phone":20,"phoneExt":7,"email":21},"CONTACT","8653188383308","zhao4wei2@hotmail.com",[23],{"facility":24,"status":25,"city":26,"state":7,"zip":7,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Shandong Public Health Clinical Center","RECRUITING","Jinan","China","CN",{"type":30,"coordinates":31},"Point",[32,33],116.99722,36.66833,{"lat":33,"lon":32},[36],{"name":37,"role":19,"phone":7,"phoneExt":7,"email":7},"Qiang Zhang",{"type":16,"investigatorFullName":39,"investigatorTitle":40,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Wei Zhao","Head of department of clinical pharmacy and pharmacology",[42],{"name":24,"class":43},"OTHER_GOV","100570771","model-informed-individualized-treatment-of-anti-infective-drugs-in-patients-with-spinal-infections-100570771",false,"NCT06711575","Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal Infections","Inclusion Criteria:\n\n* Patients with suspected\u002Fconfirmed spinal infections who are undergoing anti-infective drug therapy.\n\nExclusion Criteria:\n\n* Pregnant\u002Flactating women.\n* There are other factors that the researchers think are not suitable for inclusion","ALL",{"count":52,"type":53},300,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to describe the population pharmacokinetic characteristics in patients with suspected\u002Fconfirmed spinal infections who are undergoing anti-infective drug therapy, and to evaluate effectiveness and safety of these drugs.",[57],"Infectious Diseases of Spine","2024-11-29",{"date":60,"type":61},"2024-12-02","ACTUAL",{"date":63,"type":61},"2024-10-12",{"date":65,"type":53},"2026-10-01",{"name":5,"class":6},1]